Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Cell Biol ; 198(4): 509-28, 2012 Aug 20.
Article in English | MEDLINE | ID: mdl-22891264

ABSTRACT

Whether or not metazoan replication initiates at random or specific but flexible sites is an unsolved question. The lack of sequence specificity in origin recognition complex (ORC) DNA binding complicates genome-scale chromatin immunoprecipitation (ChIP)-based studies. Epstein-Barr virus (EBV) persists as chromatinized minichromosomes that are replicated by the host replication machinery. We used EBV to investigate the link between zones of pre-replication complex (pre-RC) assembly, replication initiation, and micrococcal nuclease (MNase) sensitivity at different cell cycle stages in a genome-wide fashion. The dyad symmetry element (DS) of EBV's latent origin, a well-established and very efficient pre-RC assembly region, served as an internal control. We identified 64 pre-RC zones that correlate spatially with 57 short nascent strand (SNS) zones. MNase experiments revealed that pre-RC and SNS zones were linked to regions of increased MNase sensitivity, which is a marker of origin strength. Interestingly, although spatially correlated, pre-RC and SNS zones were characterized by different features. We propose that pre-RCs are formed at flexible but distinct sites, from which only a few are activated per single genome and cell cycle.


Subject(s)
Chromatin/physiology , Chromatin/virology , Herpesvirus 4, Human/growth & development , Herpesvirus 4, Human/genetics , Origin Recognition Complex/genetics , Virus Replication/genetics , Burkitt Lymphoma/virology , Cell Line, Tumor , Epstein-Barr Virus Infections/virology , Humans
2.
Chromosome Res ; 18(1): 63-77, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19904620

ABSTRACT

DNA replication initiates from origins of replication following a strict sequential activation programme and a conserved temporal order of activation. The number of replication initiation sites varies between species, according to the complexity of the genomes, with an average spacing of 100,000 bp. In contrast to yeast genomes, the location and definition of origins in mammalian genomes has been elusive. Historically, mammalian replication initiation sites have been mapped in situ by systematically searching specific genomic loci for sites that preferentially initiated DNA replication, potential origins by start-site mapping and autonomously replicating sequence experiments, and potential ORC and pre-replicative complex (pre-RC) sites by chromatin immunoprecipitation (ChIP) using antibodies for pre-RC proteins. In the past decade, ChIP has become an important method for analyzing protein/DNA interactions. Classically, ChIP is combined with Southern blotting or PCR. Recently, whole genome-ChIP methods have been very successful in unicellular eukaryotes to understand molecular mechanisms coordinating replication initiation and its flexibility in response to environmental changes. However, in mammalian systems, ChIP with pre-RC antibodies has often been challenging and genome-wide studies are scarce. In this review, we will appraise the progress that has been made in understanding replication origin organization using immunoprecipitation of the ORC and Mcm2-7 complexes. A special focus will be on the advantages and disadvantages of genome-wide ChIP-technologies and their potential impact on understanding metazoan replicators.


Subject(s)
Chromatin Immunoprecipitation , Replication Origin , Eukaryotic Cells , Genome , Humans
3.
J Virol ; 84(5): 2533-46, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20032186

ABSTRACT

The Epstein-Barr virus efficiently infects human B cells. The EBV genome is maintained extrachromosomally and replicates synchronously with the host's chromosomes. The latent origin of replication (oriP) guarantees plasmid stability by mediating two basic functions: replication and segregation of the viral genome. While the segregation process of EBV genomes is well understood, little is known about its chromatin association and nuclear distribution during interphase. Here, we analyzed the nuclear localization of EBV genomes and the role of functional oriP domains FR and DS for basic functions such as the transformation of primary cells, their role in targeting EBV genomes to distinct nuclear regions, and their association with epigenetic domains. Fluorescence in situ hybridization visualized the localization of extrachromosomal EBV genomes in the regions adjacent to chromatin-dense territories called the perichromatin. Further, immunofluorescence experiments demonstrated a preference of the viral genome for histone 3 lysine 4-trimethylated (H3K4me3) and histone 3 lysine 9-acetylated (H3K9ac) nuclear regions. To determine the role of FR and DS for establishment and subnuclear localization of EBV genomes, we transformed primary human B lymphocytes with recombinant mini-EBV genomes containing different oriP mutants. The loss of DS results in a slightly increased association in H3K27me3 domains. This study demonstrates that EBV genomes or oriP-based extrachromosomal vector systems are integrated into the higher order nuclear organization. We found that viral genomes are not randomly distributed in the nucleus. FR but not DS is crucial for the localization of EBV in perichromatic regions that are enriched for H3K4me3 and H3K9ac, which are hallmarks of transcriptionally active regions.


Subject(s)
Cell Nucleus/genetics , Cell Nucleus/virology , Genome, Viral , Herpesvirus 4, Human/genetics , Replication Origin , Virus Replication/genetics , Animals , B-Lymphocytes/cytology , B-Lymphocytes/immunology , B-Lymphocytes/virology , Cell Nucleus/metabolism , Cell Nucleus/ultrastructure , Cells, Cultured , Chromatin/metabolism , Chromatin/ultrastructure , Epstein-Barr Virus Nuclear Antigens/genetics , Epstein-Barr Virus Nuclear Antigens/metabolism , Herpesvirus 4, Human/metabolism , Histones/genetics , Histones/metabolism , Humans , In Situ Hybridization, Fluorescence , Plasmids/genetics , Plasmids/metabolism
4.
Nat Cell Biol ; 11(2): 162-71, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19136966

ABSTRACT

EpCAM was found to be overexpressed on epithelial progenitors, carcinomas and cancer-initiating cells. The role of EpCAM in proliferation, and its association with cancer is poorly explained by proposed cell adhesion functions. Here we show that regulated intramembrane proteolysis activates EpCAM as a mitogenic signal transducer in vitro and in vivo. This involves shedding of its ectodomain EpEX and nuclear translocation of its intracellular domain EpICD. Cleavage of EpCAM is sequentially catalysed by TACE and presenilin-2. Pharmacological inhibition or genetic silencing of either protease impairs growth-promoting signalling by EpCAM, which is compensated for by EpICD. Released EpICD associates with FHL2, beta-catenin and Lef-1 to form a nuclear complex that contacts DNA at Lef-1 consensus sites, induces gene transcription and is oncogenic in immunodeficient mice. In patients, EpICD was found in nuclei of colon carcinoma but not of normal tissue. Nuclear signalling of EpCAM explains how EpCAM functions in cell proliferation.


Subject(s)
Antigens, Neoplasm/metabolism , Cell Adhesion Molecules/metabolism , Cell Nucleus/metabolism , Cell Proliferation , Cell Transformation, Neoplastic/metabolism , Mitosis/physiology , Signal Transduction/physiology , ADAM Proteins/metabolism , ADAM17 Protein , Active Transport, Cell Nucleus/physiology , Animals , Antigens, Neoplasm/genetics , Carcinoma/genetics , Carcinoma/metabolism , Cell Adhesion Molecules/genetics , Cell Membrane/genetics , Cell Membrane/metabolism , Cell Nucleus/genetics , Cell Transformation, Neoplastic/genetics , Colonic Neoplasms/genetics , Colonic Neoplasms/metabolism , Epithelial Cell Adhesion Molecule , Homeodomain Proteins/genetics , Homeodomain Proteins/metabolism , Humans , LIM-Homeodomain Proteins , Lymphoid Enhancer-Binding Factor 1/genetics , Lymphoid Enhancer-Binding Factor 1/metabolism , Male , Mice , Muscle Proteins/genetics , Muscle Proteins/metabolism , NIH 3T3 Cells , Presenilin-2/metabolism , Protein Structure, Tertiary , Transcription Factors/genetics , Transcription Factors/metabolism , beta Catenin/genetics , beta Catenin/metabolism
5.
J Virol ; 82(1): 126-37, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17942542

ABSTRACT

Infection with DNA viruses commonly results in the association of viral genomes with a cellular subnuclear structure known as nuclear domain 10 (ND10). Recent studies demonstrated that individual ND10 components, like hDaxx or promyelocytic leukemia protein (PML), mediate an intrinsic immune response against human cytomegalovirus (HCMV) infection, strengthening the assumption that ND10 components are part of a cellular antiviral defense mechanism. In order to further define the role of hDaxx and PML for HCMV replication, we generated either primary human fibroblasts with a stable, individual knockdown of PML or hDaxx (PML-kd and hDaxx-kd, respectively) or cells exhibiting a double knockdown. Comparative analysis of HCMV replication in PML-kd or hDaxx-kd cells revealed that immediate-early (IE) gene expression increased to a similar extent, regardless of which ND10 constituent was depleted. Since a loss of PML, the defining component of ND10, results in a dispersal of the entire nuclear substructure, the increased replication efficacy of HCMV in PML-kd cells could be a consequence of the dissociation of the repressor protein hDaxx from its optimal subnuclear localization. However, experiments using three different recombinant HCMVs revealed a differential growth complementation in PML-kd versus hDaxx-kd cells, strongly arguing for an independent involvement in suppressing HCMV replication. Furthermore, infection experiments using double-knockdown cells devoid of both PML and hDaxx illustrated an additional enhancement in the replication efficacy of HCMV compared to the single-knockdown cells. Taken together, our data indicate that both proteins, PML and hDaxx, mediate an intrinsic immune response against HCMV infection by contributing independently to the silencing of HCMV IE gene expression.


Subject(s)
Adaptor Proteins, Signal Transducing/physiology , Cytomegalovirus Infections/immunology , Cytomegalovirus/immunology , Neoplasm Proteins/physiology , Nuclear Proteins/physiology , Transcription Factors/physiology , Tumor Suppressor Proteins/physiology , Virus Replication , Cells, Cultured , Co-Repressor Proteins , Cytomegalovirus/genetics , Fibroblasts/virology , Gene Silencing , Humans , Molecular Chaperones , Neoplasm Proteins/chemistry , Nuclear Proteins/chemistry , Promyelocytic Leukemia Protein , Protein Structure, Tertiary , Transcription Factors/chemistry , Tumor Suppressor Proteins/chemistry
6.
J Virol ; 80(16): 7995-8005, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16873256

ABSTRACT

Promyelocytic leukemia (PML) nuclear bodies (also known as ND10) are nuclear substructures that contain several proteins, including PML itself, Sp100, and hDaxx. PML has been implicated in many cellular processes, and ND10 are frequently associated with the replicating genomes of DNA viruses. During herpes simplex virus type 1 (HSV-1) infection, the viral regulatory protein ICP0 localizes to ND10 and induces the degradation of PML, thereby disrupting ND10 and dispersing their constituent proteins. ICP0-null mutant viruses are defective in PML degradation and ND10 disruption, and concomitantly they initiate productive infection very inefficiently. Although these data are consistent with a repressive role for PML and/or ND10 during HSV-1 infection, evidence in support of this hypothesis has been inconclusive. By use of short interfering RNA technology, we demonstrate that depletion of PML increases both gene expression and plaque formation by an ICP0-negative HSV-1 mutant, while having no effect on wild-type HSV-1. We conclude that PML contributes to a cellular antiviral repression mechanism that is countered by the activity of ICP0.


Subject(s)
Herpesvirus 1, Human/genetics , Immediate-Early Proteins/metabolism , Neoplasm Proteins/physiology , Nuclear Proteins/physiology , Transcription Factors/physiology , Tumor Suppressor Proteins/physiology , Ubiquitin-Protein Ligases/metabolism , Adaptor Proteins, Signal Transducing/analysis , Adaptor Proteins, Signal Transducing/metabolism , Antigens, Nuclear/analysis , Antigens, Nuclear/metabolism , Autoantigens/analysis , Autoantigens/metabolism , Co-Repressor Proteins , Fibroblasts/chemistry , Fibroblasts/metabolism , Gene Expression , Gene Expression Regulation, Viral , Genome, Viral , Herpesvirus 1, Human/metabolism , Humans , Immediate-Early Proteins/analysis , Immediate-Early Proteins/genetics , Molecular Chaperones , Neoplasm Proteins/antagonists & inhibitors , Neoplasm Proteins/genetics , Nuclear Proteins/analysis , Nuclear Proteins/antagonists & inhibitors , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Promyelocytic Leukemia Protein , RNA, Small Interfering/genetics , Transcription Factors/antagonists & inhibitors , Transcription Factors/genetics , Tumor Suppressor Proteins/antagonists & inhibitors , Tumor Suppressor Proteins/genetics , Ubiquitin-Protein Ligases/analysis , Ubiquitin-Protein Ligases/genetics
7.
J Virol ; 80(16): 8006-18, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16873257

ABSTRACT

Several viruses, including human cytomegalovirus (HCMV), encode proteins that colocalize with a cellular subnuclear structure known as ND10. Since only viral DNA deposited at ND10 initiates transcription, ND10 structures were hypothesized to be essential for viral replication. On the other hand, interferon treatment induces an up-regulation of ND10 structures and viruses have evolved polypeptides that disperse the dot-like accumulation of ND10 proteins, suggesting that ND10 could also be part of an intrinsic defense mechanism. In order to obtain evidence for either a proviral or an antiviral function of ND10, we generated primary human fibroblasts with a stable, short interfering RNA-mediated knockdown (kd) of PML. In these cells, other ND10-associated proteins like hDaxx showed a diffuse nuclear distribution. Interestingly, we observed that HCMV infection induced the de novo formation of ND10-like hDaxx and Sp100 accumulations that colocalized with IE2 and were disrupted, in the apparent absence of PML, in an IE1-dependent manner during the first hours after infection. Furthermore, infection of PML-kd cells with wild-type HCMV at a low multiplicity of infection resulted in enhanced replication. In particular, a significantly increased plaque formation was detected, suggesting that more cells are able to support initiation of replication in the absence of PML. While there was no difference in viral DNA uptake between PML-kd and control cells, we observed a considerable increase in the number of immediate-early (IE) protein-positive cells, indicating that the depletion of PML augments the initiation of viral IE gene expression. These results strongly suggest that PML functions as part of an intrinsic immune mechanism against cytomegalovirus infections.


Subject(s)
Cytomegalovirus Infections/immunology , Cytomegalovirus Infections/metabolism , Cytomegalovirus/physiology , Gene Expression Regulation, Viral , Neoplasm Proteins/metabolism , Nuclear Proteins/metabolism , Transcription Factors/metabolism , Tumor Suppressor Proteins/metabolism , Virus Replication/genetics , Adaptor Proteins, Signal Transducing/analysis , Adaptor Proteins, Signal Transducing/metabolism , Antigens, Nuclear/analysis , Antigens, Nuclear/metabolism , Autoantigens/analysis , Autoantigens/metabolism , Cell Nucleus/chemistry , Cell Nucleus/metabolism , Cell Nucleus/virology , Co-Repressor Proteins , Fibroblasts/chemistry , Fibroblasts/metabolism , Fibroblasts/virology , Humans , Immediate-Early Proteins/genetics , Immediate-Early Proteins/metabolism , Molecular Chaperones , Neoplasm Proteins/antagonists & inhibitors , Neoplasm Proteins/genetics , Nuclear Proteins/analysis , Nuclear Proteins/antagonists & inhibitors , Nuclear Proteins/genetics , Promyelocytic Leukemia Protein , Trans-Activators/genetics , Trans-Activators/metabolism , Transcription Factors/antagonists & inhibitors , Transcription Factors/genetics , Tumor Suppressor Proteins/antagonists & inhibitors , Tumor Suppressor Proteins/genetics , Viral Proteins/genetics , Viral Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...